Vor Biopharma Inc (VOR) is a Healthcare · Biotechnology company listed on NASDAQ. Price $21.30 (-2.70%), Market cap $0.79B, 52-week low–high $0.17 ~ $48.72.
Vor Biopharma Inc., a clinical-stage biopharmaceutical company, focuses on the development of a novel therapy in the treatment of autoimmune diseases. The company offers telitacicept, a novel fusion protein for the treatment of generalized myasthenia gravis, systemic lupus erythematosus, and rheumatoid arthritis, as well as Sjögren's disease and IgA nephrapathy. It has a license agreement with RemeGen Co., Ltd. for the exploitation, development, and commercialization of telitacicpet and related products. The company was incorporated in 2015 and is headquartered in Boston, Massachusetts.
Financial statements, price targets, institutional (13F) holdings and related news for Vor Biopharma Inc are updated in real time on BlackAll Trade.
Vor Biopharma Inc trades at $21.30 (-2.70%). Real-time quotes and charts are available on BlackAll Trade.
Vor Biopharma Inc has a market cap of about $0.79B.
Vor Biopharma Inc., a clinical-stage biopharmaceutical company, focuses on the development of a novel therapy in the treatment of autoimmune diseases. The company offers telitacicept, a novel fusion p